Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Taub RebeccaDirector |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $160K 299 sh | Jan 13, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $110K 200 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $154K 280 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $207K 385 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $229K 440 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $177K 332 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $216K 400 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 13 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $88K 166 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 11 | Baig SaqibChief Accounting Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $35K 5,000 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 11 | McCarthy Brian K.Pres.,Global Sales & Field Ops | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $140K 2,000 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 11 | Congleton JonDirector, Chief Executive Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $236K 7,117 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $21K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Thygesen Allan C.Director, President and CEO |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $21K 300 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $48K 89 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $16K 30 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $344K 2,347 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer |  INSMINSMED IncOpen-market sale · 10b5-1 plan | SELL | $351K 1,887 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $481K 3,264 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $481K 3,263 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $344K 2,347 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 7 | Wu LeiDirector, Chief Executive Officer, 10% Owner |  GCTGigaCloud Technology IncOpen-market sale · 10b5-1 plan | SELL | $745K 17.7K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $65K 450 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $65K 450 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $213K 1,435 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $213K 1,435 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Patel AnishCHIEF OPERATING OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $6,926 243 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Majalya Sidney A.SVP, CLO and Secretary |  TNETTRINET GROUP, INC.Open-market sale · 10b5-1 plan | SELL | $48K 775 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 4 |  Dines DanielDirector, CEO and Chairman, 10% Owner |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $773K 45.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Lee JanetGC & Corporate Secretary |  SNPSSYNOPSYS INCOpen-market sale · 10b5-1 plan | SELL | $133K 250 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $703K 16.8K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $96K 2,265 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $392K 9,059 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | GCTGigaCloud Technology Inc Open-market sale · 10b5-1 plan | SELL | $303K 6,841 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $25K 170 sh | Jan 13, 2026 traded Jan 12, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K